Analyst Comments
Provided by:
Set Up E-mail Alerts For Analyst Comments »
The top source for Wall Street analyst comments, price target and estimate changes, and speculation.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
This page tracks and reports on important analyst comments in real-time. Upgrade to StreetInsider.com Premium to get a daily listing of 'Hot Comments,' or the best daily comments as we see them. Premium members can also receive e-mail/mobile alerts on important dividend events. 2-Week Free Trial available.
-
BMO Capital Starts Trevi Therapeutics (TRVI) at Outperform
-
BMO Capital Starts Insmed (INSM) at Outperform
-
Jefferies Reiterates Underperform Rating on Tempus AI Inc (TEM)
-
-
-
-
-
-
-
UnitedHealth Group (UNH) PT Raised to $493 at Mizuho
-
-
-
-
-
-
-
Mizuho n Acadia Pharmaceuticals (ACAD): 'we view risk/reward as skewed significantly to the upside'
-
-
-
-
-
-
-
Nebius Group (NBIS) PT Raised to $410 at Northland
-
-
-
-
-
-
-
Simmons First National (SFNC) PT Raised to $24 at DA Davidson
-
-
-
-
-
-
-
DA Davidson Reiterates Buy Rating on ACI Worldwide (ACIW)
-
-
-
-
-
-
-
NextEra Energy (NEE) PT Lowered to $95 at BMO Capital
-
-
-
-
-
482,070 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving Analyst Comments reports.

